| scholarly article | Q13442814 |
| P50 | author | Suresh Veeramani | Q81232148 |
| P2093 | author name string | Surinder K Batra | |
| Ming-Fong Lin | |||
| Satyendra Kumar | |||
| Tsai-Der Chuang | |||
| Yaping Tu | |||
| Fen-Fen Lin | |||
| Siu-Ju Chen | |||
| P2860 | cites work | Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells | Q22254244 |
| ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner | Q24293488 | ||
| Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine | Q24336492 | ||
| Phosphotyrosine interactome of the ErbB-receptor kinase family | Q24672516 | ||
| Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells | Q28115368 | ||
| Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells | Q28118863 | ||
| ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases | Q28198475 | ||
| Molecular determinants of resistance to antiandrogen therapy | Q28236889 | ||
| Molecular cloning and sequence analysis of cDNA encoding human prostatic acid phosphatase | Q28281223 | ||
| ShcA signalling is essential for tumour progression in mouse models of human breast cancer | Q28590157 | ||
| STATs in oncogenesis | Q29617571 | ||
| ERBB receptors and cancer: the complexity of targeted inhibitors | Q29619520 | ||
| c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential | Q30157161 | ||
| c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function | Q30303639 | ||
| Mechanism of biological synergy between cellular Src and epidermal growth factor receptor | Q30454480 | ||
| Activation of mitogen-activated protein kinase associated with prostate cancer progression. | Q30473093 | ||
| Jun D cooperates with p65 to activate the proximal kappaB site of the cyclin D1 promoter: role of PI3K/PDK-1. | Q33313243 | ||
| Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis | Q33879512 | ||
| Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage | Q34103621 | ||
| Combinatorial control of the specificity of protein tyrosine phosphatases | Q34180660 | ||
| Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate | Q34215208 | ||
| Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications. | Q35741626 | ||
| Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer. | Q36328606 | ||
| Stat3 promotes metastatic progression of prostate cancer. | Q36691140 | ||
| Tyrosyl kinase activity is inversely related to prostatic acid phosphatase activity in two human prostate carcinoma cell lines | Q36902866 | ||
| Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product | Q37146015 | ||
| Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors | Q37205574 | ||
| Revisiting histidine-dependent acid phosphatases: a distinct group of tyrosine phosphatases. | Q37417021 | ||
| A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway | Q37634563 | ||
| Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo | Q38293021 | ||
| The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain | Q38336919 | ||
| Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells | Q38459479 | ||
| Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment | Q39847370 | ||
| Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. | Q39916314 | ||
| Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation | Q39980991 | ||
| Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells. | Q40183496 | ||
| Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations | Q40342379 | ||
| Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells | Q40584396 | ||
| HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. | Q40832627 | ||
| A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. | Q41615181 | ||
| Human prostatic acid phosphatase has phosphotyrosyl protein phosphatase activity | Q42853246 | ||
| Cooperative kinetics of human prostatic acid phosphatase | Q43713572 | ||
| Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model | Q43900265 | ||
| ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells | Q44304000 | ||
| Suppression of LNCaP prostate cancer xenograft tumors by a prostate‐specific protein tyrosine phosphatase, prostatic acid phosphatase | Q44415199 | ||
| Concentration-dependent dissociation/association of human prostatic acid phosphatase | Q44577249 | ||
| Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers | Q44706680 | ||
| Theoretical investigations of prostatic acid phosphatase. | Q45172733 | ||
| The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells | Q46372887 | ||
| Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells | Q46502297 | ||
| Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells. | Q46516593 | ||
| Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression | Q47718793 | ||
| Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential | Q47814156 | ||
| Her-2-neu expression and progression toward androgen independence in human prostate cancer. | Q53800928 | ||
| Androgen receptor outwits prostate cancer drugs. | Q53907010 | ||
| Human epidermal receptor-2 expression in prostate cancer. | Q54784831 | ||
| A phosphotyrosyl-protein phosphatase activity associated with acid phosphatase from human prostate gland | Q57980223 | ||
| HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer | Q61510069 | ||
| Comparison of human prostatic acid phosphatase by measurement of enzymatic activity and by radioimmunoassay | Q67540671 | ||
| Purification and characterization of a new human prostatic acid phosphatase isoenzyme | Q70429865 | ||
| Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase | Q71530400 | ||
| Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor | Q72237387 | ||
| Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines | Q74263775 | ||
| Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells | Q80438682 | ||
| Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence | Q81098692 | ||
| P433 | issue | 31 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| cell growth | Q189159 | ||
| P304 | page(s) | 23598-23606 | |
| P577 | publication date | 2010-05-24 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth | |
| P478 | volume | 285 |
| Q38017593 | A molecular description of acid phosphatase |
| Q28397032 | Androgens upregulate Cdc25C protein by inhibiting its proteasomal and lysosomal degradation pathways |
| Q34115708 | Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells |
| Q38084832 | Atypical protein phosphatases: emerging players in cellular signaling |
| Q35857477 | Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression. |
| Q26863333 | Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor |
| Q26742062 | Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer |
| Q91790579 | ErbB-2 signaling in advanced prostate cancer progression and potential therapy |
| Q36048017 | ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells |
| Q35596729 | Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells. |
| Q36913762 | Human prostatic acid phosphatase: structure, function and regulation |
| Q50217907 | Identification of urinary protein biomarkers for tobacco smoking |
| Q35760870 | Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. |
| Q64235092 | Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase |
| Q39335108 | N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer |
| Q28545928 | Novel Imidazopyridine Derivatives Possess Anti-Tumor Effect on Human Castration-Resistant Prostate Cancer Cells |
| Q30573685 | Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment |
| Q34273059 | Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells |
| Q35543331 | Screening and characterization of a novel RNA aptamer that specifically binds to human prostatic acid phosphatase and human prostate cancer cells |
| Q24306734 | Secretion and N-linked glycosylation are required for prostatic acid phosphatase catalytic and antinociceptive activity |
| Q28534235 | Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease |
| Q38735989 | Statin derivatives as therapeutic agents for castration-resistant prostate cancer. |
| Q51577116 | The Extended Family of Protein Tyrosine Phosphatases. |
| Q39397231 | The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression |
| Q38634867 | The extended human PTPome: a growing tyrosine phosphatase family |
| Q27308107 | Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma |
| Q33983890 | p66Shc longevity protein regulates the proliferation of human ovarian cancer cells |
| Q49808005 | p66Shc regulates migration of castration-resistant prostate cancer cells |
Search more.